(Q34115362)

31 July 2017

0 references

1 reference

title

Abnormal breath testing in IBS: a meta-analysis (English)

1 reference

31 July 2017

0 references

1 reference

Mark Pimentel

1 reference

31 July 2017

Eric D Shah

1 reference

31 July 2017

Robert J Basseri

series ordinal

1 reference

31 July 2017

Kelly Chong

series ordinal

1 reference

31 July 2017

publication date

14 May 2010

1 reference

Digestive Diseases and Sciences

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

2441-2449

1 reference

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-010-1276-4

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

12 December 2020

Use and abuse of hydrogen breath tests

1 reference

12 December 2020

Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation

1 reference

12 December 2020

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

1 reference

12 December 2020

The impact of irritable bowel syndrome on health-related quality of life

1 reference

12 December 2020

[Diagnosis of bacterial contamination of the small intestine using the 1 g [14C] xylose breath test in various gastrointestinal diseases]

1 reference

12 December 2020

Controlling the risk of spurious findings from meta-regression.

1 reference

12 December 2020

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

1 reference

12 December 2020

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.

1 reference

12 December 2020

Costs of irritable bowel syndrome in the UK and US.

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis

1 reference

12 December 2020

Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria

1 reference

12 December 2020

Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

1 reference

12 December 2020

The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment

1 reference

12 December 2020

Prevalence of irritable bowel syndrome: a community survey

1 reference

12 December 2020

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

1 reference

12 December 2020

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls

1 reference

12 December 2020

Comparison of breath testing with fructose and high fructose corn syrups in health and IBS.

1 reference

12 December 2020

Impact of irritable bowel syndrome on quality of life

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

12 December 2020

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

1 reference

12 December 2020

Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study

1 reference

12 December 2020

Evaluating breath methane as a diagnostic test for constipation-predominant IBS.

1 reference

12 December 2020

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

12 December 2020

Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

1 reference

12 December 2020

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

12 December 2020

Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study

1 reference

12 December 2020

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

1 reference

12 December 2020

Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study

1 reference

12 December 2020

Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.

1 reference

12 December 2020

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

10.1007/S10620-010-1276-4

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1052749079

0 references

1 reference